ENTITY
Mark Cuban's Cost Plus Drug Company
Mark Cuban's Cost Plus Drug Company
PulseAugur coverage of Mark Cuban's Cost Plus Drug Company — every cluster mentioning Mark Cuban's Cost Plus Drug Company across labs, papers, and developer communities, ranked by signal.
Total · 30d
2
2 over 90d
Releases · 30d
0
0 over 90d
Papers · 30d
0
0 over 90d
TIER MIX · 90D
TOPICS
SENTIMENT · 30D
1 day(s) with sentiment data
RECENT · PAGE 1/1 · 2 TOTAL
-
Humana sells Gentiva stake for $900M to focus on CenterWell
Humana is selling its minority stake in Gentiva, a leading end-of-life care provider, for $900 million. This divestiture is part of Humana's ongoing strategy to shed non-core assets and refocus on its CenterWell healthc…
-
White House drug price savings claims face scrutiny over flawed math
The White House has projected significant cost savings, potentially over $500 billion in a decade, from its "most favored nation" drug pricing policy, which pegs U.S. drug prices to those in comparable wealthy nations. …